drugset / Trial / NCT07135128

A Clinical Study of [225Ac]Ac-FAPI-XT(XT117) Injection in Patients With Advanced Solid Tumors

NCT07135128 ↗

Phase 1 Recruiting 20 enrolled Xiaorong Sun
NaSequentialOpen-labelTreatment

Summary

This is a single-center, single-arm clinical study to evaluate the safety, tolerability and preliminary efficacy of \[225Ac\]Ac-FAPI-XT injection in patients with FAP-positive advanced solid tumors.

Timeline

Start
2024-10-14
Primary completion
2026-06-30
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 225Ac-FAPI-XT Unknown — —